• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: NOVO NORDISK A/S, MEDICAL SYSTEMS NOVOPEN 4; INSULIN DELIVERY DEVICE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

NOVO NORDISK A/S, MEDICAL SYSTEMS NOVOPEN 4; INSULIN DELIVERY DEVICE Back to Search Results
Model Number N/A
Device Problems Defective Component (2292); Failure to Deliver (2338)
Patient Problems Hyperglycemia (1905); Coma (2417)
Event Type  Injury  
Event Description
No insulin that comes out of the tip [device failure].The piston rod moves quickly [device malfunction].He fell into diabetic coma twice [diabetic coma].Case description: (b)(6).Study description: main objective of the programme is to help patients to understand their diabetes and maintain normal life through qualified educators who offer simple and practical information directly to the patients and also, train patients on how to use their insulin devices and needles etc.Patient's height, weight and body mass index (bmi) was not reported.This serious solicited report from egypt was reported by a consumer as "no insulin that comes out of the tip(device failure)" with an unspecified onset date , "the piston rod moves quickly(device component malfunction)" with an unspecified onset date , "he fell into diabetic coma twice(diabetic coma)" with an unspecified onset date and concerned a male patient (age not reported) who was treated with novopen 4 (insulin delivery device) from unknown start date and ongoing for "device therapy", mixtard 30 hm penfill (insulin human) suspension for injection, 100 iu/ml dose, frequency & route used- unk, unknown from unknown start date and ongoing for "drug use for unknown indication".Medical history was not provided.It was reported that there was no insulin that come out of the tip of the pen and novopen piston rode was moving quickly.It was reported that patient experienced diabetic coma twice because of this pen.The patient was in general reuse the needles and the needle left attached to the pen in between injections.The force needed to inject felt different from normal (easier).Patient used to resuspend the insulin suspension (cloudy insulin) before use.The patient was trained by a health care professional in the use of the novopen.There were no recent change in diet or exercise level.The needle attached to the pen in a 180 degree angle (straight on).The patient had not recently changed from another novopen to the current novopen.Batch numbers: novopen 4: jvgp825, mixtard 30 hm penfill: kr76f34.Action taken to novopen 4 was reported as no change action taken to mixtard 30 hm penfill was reported as no change.The outcome for the event "no insulin that comes out of the tip(device failure)" was not reported.The outcome for the event "the piston rod moves quickly(device component malfunction)" was not reported.The outcome for the event "he fell into diabetic coma twice(diabetic coma)" was not reported.Reporter's causality (novopen 4): no insulin that comes out of the tip(device failure): probable.The piston rod moves quickly(device component malfunction): probable.He fell into diabetic coma twice(diabetic coma): probable.Company's causality (novopen 4) - no insulin that comes out of the tip(device failure): possible.The piston rod moves quickly(device component malfunction): possible.He fell into diabetic coma twice(diabetic coma): possible.Reporter's causality (mixtard 30 hm penfill): no insulin that comes out of the tip(device failure): probable.The piston rod moves quickly(device component malfunction): probable.He fell into diabetic coma twice(diabetic coma): probable.Company's causality (mixtard 30 hm penfill) - no insulin that comes out of the tip(device failure): possible.The piston rod moves quickly(device component malfunction): possible.He fell into diabetic coma twice(diabetic coma): possible.Preliminary manufacturer's comment: 29-oct-2021: the suspected device novopen 4 has not been returned to novo nordisk for evaluation.No conclusion is reached.Company comment: diabetic coma is assessed as listed event according to the novo nordisk current ccds in mixtard 30 hm penfill.Relevant information on patient age, duration of diabetes mellitus, complications, therapy details with mixtard 30 penfill, investigation results of suspected products (device and drug), outcome of the event and action taken with suspect product are unavailable for complete causality assessment.This single case report is not considered to change the current knowledge of the safety profile of mixtard 30penfill.
 
Event Description
Case description: investigational result: name: novopen 4 batch number: jvgp825 the product was not returned for examination.If possible, please forward the reported product(s) for further investigations.Name: mixtard 30 penfill batch number: kr76f34 the product was not returned for examination.If possible, please forward the reported product(s) for further investigations since last submission, the case has been updated with the following: - inv result updated - b, c, d and g codes were added.- narrative updated accordingly final manufacturer's comment: 14-jan-2022: the suspected device novopen 4 has not been returned to novo nordisk for evaluation.No abnormalities relating to the observed problem were found in the reference sample analysis.The batch documentation has been reviewed and found to be normal.With the available limited information regarding the handling of the suspected device, it is not possible to identify a clear root cause in relation to functionality of novopen 4.H3 continued: evaluation summary name: novopen 4 batch number: jvgp825 the product was not returned for examination.If possible, please forward the reported product(s) for further investigations.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
NOVOPEN 4
Type of Device
INSULIN DELIVERY DEVICE
Manufacturer (Section D)
NOVO NORDISK A/S, MEDICAL SYSTEMS
hilleroed,,
DA 
Manufacturer (Section G)
NOVO NORDISK A/S, MEDICAL SYSTEMS
brennum park
hilleroed,, 3400
DA   3400
Manufacturer Contact
p.o. box 846
plainsboro,, NJ 08536
8007276500
MDR Report Key12818824
MDR Text Key285256421
Report Number9681821-2021-00070
Device Sequence Number1
Product Code FMF
Combination Product (y/n)Y
Reporter Country CodeEG
PMA/PMN Number
20-986
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Study,Consumer
Reporter Occupation Non-Healthcare Professional
Type of Report Initial,Followup
Report Date 10/24/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received11/16/2021
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Lay User/Patient
Device Expiration Date01/05/2024
Device Model NumberN/A
Device Catalogue Number185490
Device Lot NumberJVGP825
Was Device Available for Evaluation? No
Date Manufacturer Received01/07/2022
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured01/06/2019
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Reuse
Patient Sequence Number1
Patient Outcome(s) Other;
Patient SexMale
-
-